Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
REVIEW ARTICLE  

 Article Access Statistics
    Viewed45080    
    Printed1130    
    Emailed106    
    PDF Downloaded3441    
    Comments [Add]    
    Cited by others 9    

Recommend this journal

Clinical Review: Management of weaning from cardiopulmonary bypass after cardiac surgery


1 Department of Anaesthesiology, Pharmacology and Intensive Care, University of Geneva, CH-1211 Geneva
2 Department of Cardiovascular Surgery,of the University Hospital, Faculty of Medicine, University of Geneva, CH-1211 Geneva
3 Department of Anesthesia and Intensive Care, Cardiocentro Ticino, CH-6900 Lugano

Correspondence Address:
Marc Licker
Department of Anesthesiology, Pharmacology & Intensive Care, University Hospital Geneva, rue Gabrielle-Perret-Gentil 4, CH-1211 Geneva 14

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.97977

Rights and Permissions

Year : 2012  |  Volume : 15  |  Issue : 3  |  Page : 206-223

 

SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (700 KB)
Email article
Print Article
Add to My List
A sizable number of cardiac surgical patients are difficult to wean off cardiopulmonary bypass (CPB) as a result of structural or functional cardiac abnormalities, vasoplegic syndrome, or ventricular dysfunction. In these cases, therapeutic decisions have to be taken quickly for successful separation from CPB. Various crisis management scenarios can be anticipated which emphasizes the importance of basic knowledge in applied cardiovascular physiology, knowledge of pathophysiology of the surgical lesions as well as leadership, and communication between multiple team members in a high-stakes environment. Since the mid-90s, transoesophageal echocardiography has provided an opportunity to assess the completeness of surgery, to identify abnormal circulatory conditions, and to guide specific medical and surgical interventions. However, because of the lack of evidence-based guidelines, there is a large variability regarding the use of cardiovascular drugs and mechanical circulatory support at the time of weaning from the CPB. This review presents key features for risk stratification and risk modulation as well as a standardized physiological approach to achieve successful weaning from CPB.






[FULL TEXT] [PDF]*
 

 

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 REVIEW ARTICLE
 




1 Department of Anaesthesiology, Pharmacology and Intensive Care, University of Geneva, CH-1211 Geneva
2 Department of Cardiovascular Surgery,of the University Hospital, Faculty of Medicine, University of Geneva, CH-1211 Geneva
3 Department of Anesthesia and Intensive Care, Cardiocentro Ticino, CH-6900 Lugano

Correspondence Address:
Marc Licker
Department of Anesthesiology, Pharmacology & Intensive Care, University Hospital Geneva, rue Gabrielle-Perret-Gentil 4, CH-1211 Geneva 14

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.97977

Rights and Permissions

A sizable number of cardiac surgical patients are difficult to wean off cardiopulmonary bypass (CPB) as a result of structural or functional cardiac abnormalities, vasoplegic syndrome, or ventricular dysfunction. In these cases, therapeutic decisions have to be taken quickly for successful separation from CPB. Various crisis management scenarios can be anticipated which emphasizes the importance of basic knowledge in applied cardiovascular physiology, knowledge of pathophysiology of the surgical lesions as well as leadership, and communication between multiple team members in a high-stakes environment. Since the mid-90s, transoesophageal echocardiography has provided an opportunity to assess the completeness of surgery, to identify abnormal circulatory conditions, and to guide specific medical and surgical interventions. However, because of the lack of evidence-based guidelines, there is a large variability regarding the use of cardiovascular drugs and mechanical circulatory support at the time of weaning from the CPB. This review presents key features for risk stratification and risk modulation as well as a standardized physiological approach to achieve successful weaning from CPB.






[FULL TEXT] [PDF]*


        
Print this article     Email this article